Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Goletti, M. P. Parracino, O. Butera, F. Bizzoni, S. Carrara, D. Vincenti, R. Casetti, D. Dainotto, G. Anzidei, C. Nisii, G. Ippolito, F. Poccia, E. Girardi (Rome, Italy). Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to mycobacterium tuberculosis: a pilot study. Eur Respir J 2007; 30: Suppl. 51, 4448

Member's Comments

No comment yet.

Related content which might interest you: Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 363s Year: 2006 RD1-epitopes response correlates with the time since first exposure in close contacts recently exposed to mycobacterium tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs Source: Eur Respir J, 55 (3) 1902048; 10.1183/13993003.02048-2019 Year: 2020 Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 A double blind randomized study of aminoglycoside infusion with combined therapy for pulmonary mycobacterium avium complex disease Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis Year: 2006 Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis: contribution of murine studies Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020 Year: 2021 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan Source: International Congress 2017 – Migrants and screening Year: 2017 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection Source: Eur Respir J 2012; 40: 1450-1457 Year: 2012 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Multi drug resistant (rifampicin + isoniazid) pulmonary tuberculosis – a challenge for a developing country specially co-infected with HIV Source: Eur Respir J 2007; 30: Suppl. 51, 421s Year: 2007 Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment Source: International Congress 2017 – Migrants and screening Year: 2017 Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens Source: Eur Respir J 2010; 36: 355 Year: 2010